Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic A (Q36464652)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic A |
scientific article |
Statements
1 reference
Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic A (English)
1 reference
Per Ljungman
1 reference
Gerard Socie
1 reference
Judith Marsh
1 reference
Andre Tichelli
1 reference
Hubert Schrezenmeier
1 reference
Britta Hochsmann
1 reference
Antonio M Risitano
1 reference
Monika Fuehrer
1 reference
Albert N Bekassy
1 reference
Elizabeth T Korthof
1 reference
Anna Locasciulli
1 reference
Andrea Bacigalupo
1 reference
Bruce Camitta
1 reference
Neal S Young
1 reference
Jakob Passweg
1 reference
European Group for Blood and Marrow Transplantation (EBMT) Severe Aplastic Anaemia Working Party
1 reference
26 May 2010
1 reference
1 reference
377-379
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference